The Sydney Brain Centre at UNSW promotes and conducts internationally competitive clinical trials and translational stroke and neuroscience research. Our research primarily focuses on early diagnosis, improving access to and delivery of hyper-acute and acute stroke management. We know that “time is brain’ and we are working with state and district ambulance services, acute hospitals, and consumer groups to improve services and outcomes for people experiencing stroke.
Our team is led by Professor Mark Parsons, Professor of Medicine and Neurology at UNSW, an internationally recognised leader in stroke. The Sydney Brain Centre is based at the Ingham Institute for Applied Medical Research and South West Sydney Local Health District. Working with Professor Parsons is a multidisciplinary and international team of researchers and clinicians, working with an extensive network of clinicians, academics, and consumers.
Our goals
Our research focuses on improving the quality and outcomes for stroke survivors. Professor Parsons and the team lead international trials to improve understanding of the most effective treatments for acute stroke. The team also supports studies to translate new evidence into practice and we are involved in several implementation studies, including the use of novel technologies and in partner with key health, academic and industry partners to reduce the severity of disability associated with stroke. Other patient trials include migraine, dementia and rare neurological disorders such as Chronic Demyelinating polyneuropathy.
Research strengths
- Multidisciplinary international team with expertise in stroke, neurology, neuroimaging, rehabilitation and AI
- Leading international clinical trials and implementation studies to improve stroke practice
- Well-established collaborations with national and international health systems, hospitals, universities, consumers and community groups, and industry partners
- Delivering infrastructure support to hot large imaging database and deliver high-power computers to support the imaging process and artificial intelligence capabilities.
Our people
The UNSW Sydney Brain Centre Team includes a diverse multidisciplinary team: we have well-established pathways for nurturing new research talent, including promising early career fellows (Dr Lin, Dr Dos Santos, Dr Blair, Dr Badge). Our team currently supports a combined total of 19 PhD candidates and 15 postdoctoral fellows.
Research staff
- Timmy Phan, Project Manager – Imaging
- Jordan Rogers, Senior Trials Coordinator
- Sarika Pandit, Trials Coordinator
- James Stewart, Research Assistant
- Tom Dobell-Brown, Research Assistant
PhD Candidates
UNSW students 2024
- Jessica Ly, Honours student, MD
- Nathan Lotter
- Oliver Sidgreaves
UNSW students 2023
- Pui Lok Annette Fung, Honours student
- Deena Alysha Coilpillai Chelliah Vernon, ILP student
Partnerships
Professor Parsons and the Sydney Brain Centre collaborate with over 50 sites (>4000 patients) through the ETERNAL, TACTICS, TASTE, and MOSES clinical trials in Australia, Europe, Canadian, Chinese, and Japanese hospitals and universities. Professor Mark Parsons is the CIA for both the INSPIRE and TASTE
Health system partners
- South West Sydney Local Health District (LHD)
- eHealth NSW
- Hunter New England LHD
- NSW Ambulance
- Ambulance Victoria
- Royal Melbourne Hospital
University and research partners
- University of NSW
- University of Melbourne
- University of Newcastle
- Australian Stroke Alliance
- Maridulu Budyari Gumal (Sydney Partnership for Health, Education, Research and Enterprise [SPHERE])
- University of Wollongong
Industry collaborations
- Siemens
- Canon/Toshiba
- GE
- EMVision
- Micro X
- Telstra
- Amazon Web Services (AWS)
- Apollo Medical Imaging
Our research
In the short time since the inception of the Sydney Brain Centre began in July 2020. The team has obtained significant grant funding, and key programs of research include:
-
Professor Mark Parsons and Associate Professor Andrew Bivard are Program Leads and Investigators for the Australian Stroke Alliance, which includes national and state government, academic, health, consumer, and commercial partners. The Alliance aims to trial and implement innovative technical and tele-health solutions to radically transform access to early pre-hospital. Rather than transporting patients to hospital, we drive or fly Australian-designed life-saving brain scanning equipment and time-critical stroke treatment directly to the patient, whether they live in out-metropolitan, rural, regional or remote communities, transforming their chances of survival and recovery.
-
The stroke capable ambulance is one of the Alliance studies currently being implemented in South West Sydney LHD and the Royal Melbourne Hospital and John Hunter Hospital, focusing on implementing new models of care and novel technologies including communication apps and imaging into Ambulances for earlier more accurate diagnosis of stroke in the field, and faster access to time-critical treatments.
-
INSPIRE is the world’s largest stroke perfusion imaging registry, with >5000 stroke patients with advanced imaging and clinical data from Australian, Chinese, Canadian, Japanese and Indian centres. INSPIRE aims to establish an internationally unique web-based database of imaging and clinical stroke data to:
- Measure outcomes of advanced CT stroke imaging.
- Assess whether the implementation of quality use of advanced CT imaging improves the safe and effective delivery of reperfusion treatment.
- Develop a Quality Assurance Framework for advanced CT imaging in stroke with standardisation of the post-processing and reporting of advanced CT.
-
MOSES aims to develop a framework for comparing imaging and clinical data in thrombectomy patients between Comprehensive Stroke Centres and use these data to:
- Develop more specific clinical and imaging selection guidelines for thrombectomy patient selection. This will include guidelines to better select which patients (using multimodal CT and telestroke) should be transported from regional Primary Stroke Centres (PSCs) for thrombectomy.
- Develop a decision-assistance tool using clinical and multimodal CT data to help guide clinicians in patient selection for acute reperfusion therapy (thrombectomy and/or IV thrombolysis)
-
Year/Sponsor/Amount
Name
Chief Investigators
2021-2022: Ingham Institute Cardiovascular Research Grant, AUD $75,000
Colchicine After Stroke/Heart Attack to Prevent Event Recurrence – PET Scan Outcomes (CASPER-PET Trial).
Blair C, Parsons M. 2021-2022: UNSW Medicine & Health Cardiac, Vascular and Metabolic Medicine (CVMM) Theme: Big Ideas Seed Grant Scheme, AUD $150,000. Clinical and Imaging Characterisation of Stroke in First Nations, Pacific Islander, and other Culturally and Linguistically Diverse Australian Communities. Parsons M, Lin L, Blair C
2022-2026: National Health and Medical Research Council of Australia (NHMRC) Cardiovascular Health Grant (APP2017083), AUD $999.632. Non-invasive imaging of atherosclerotic plaque: quantification of disease activity for improved identification of patients with residual cardiovascular risk.
Stockler R, Patel S, Keech A, Lin P, Parsons M, Chen J, Celermajer D, Kiat H, Levi C, Rashid I, Robledo K, Blair C, Nadel J. 2022-2026: National Health and Medical Research Council of Australia (NHMRC) Clinical Trials and Cohorts Grant (APP2015020), $1,535,099
Magnetic Resonance Imaging outcomes in the Colchicine After Stroke to Prevent Event Recurrence (MR-CASPER trial). Parsons MW, Brodtmann A, Bivard A, Keech A, Vagal A, Churilov L, Patel S, Parizel P, Butcher K, Campbell B. 2022-2026: NHMRC 2021 Synergy Grants (APP2010766), $5,000,000
SERPICO Stroke: Synergistic Enhancement of Research design with Precision analytics to Improve Clinical Outcomes in Stroke Parsons M, Bivard A, Brodtmann A, Levi C, Moodie M, Churilov L, Holliday E, Delcourt C, Ferguson C. 2022-2026: NHMRC Centres of Research Excellence (APP2006765), $3,000,000 Vascular Contributions to Dementia (VCD-CRE) - a transformative approach to reducing the
burden of cognitive disorders
Perminder Sachdev, Parsons M, Brodtmann A, Levi C, Samaras K, Kovacic J, O’Sullivan M J, Butcher K, Bivard A, Gupta V. 2022-2026: NHMRC Partnership Projects (APP2006751), $1,164,847 Talk stroke: Developing Australia's first National tele stroke framework and communication platform Parsons M, Bivard A, Levi C, Churilov L, Moodie M, Chow J, Davis S, Bladin C, McGowan S, Muller C. 2022-2026: Medical Research Futures Fund (MRFF) Cardiovascular Mission Grant (APP2007317), $1,526,318
Stroke in patients with large Ischaemic Core: Assessment of Reperfusion therapy Impact on Outcome
(SICARIO)
Levi C, Bivard A, Parsons M, Churilov L, Butcher K, Moodie M, Holliday E, Spratt N, Bladin C, Yan B. 2021-2026: MRFF Frontier Health and Medical Research Grant, (RHRHPSI000005), $40,167,050 The Stroke Golden Hour: Delivering Urgent Stroke Care to all Australians. The Australian Stroke Alliance. Program Stream leads and CIs: Parsons MW, Bladin C, Churilov L. 2021-2025: Medical Research Futures Fund (MRF1200267), $1,006,075 Neurological Disorders Grant: MIDAS-2 trial (Reducing debilitating fatigue after stroke to improve
Quality of Life).
Levi C, Bivard A, Parsons MW, Donnan GD, Khan F, Moodie M, Bajorek B, Butcher K, Markus H, Nilsson M. 2021 – 2024: Ingham Institute for Applied Medical Research and the Technion – Israel Institute of Technology, $350,000 Stroke Smart Ambulance: The Ambulance of the Future: developing capability for a new ambulance model of care, designated the ‘Smart Ambulance’, which will use our unique communications hub to transfer real-time clinical data from the ambulance to the hospital teams. Parsons MW, Lange D, Behar J, Middleton P, Christie L 2020-2024: NHMRC Clinical Trials and Cohorts Grant (APP1182533), $2,750,598
ETERNAL (Extending the Time window for Tenecteplase by Effective Reperfusion of peNumbraL tissue in patients with large vessel occlusion). Parsons MW, Butcher K, Campbell B, Churilov L, Davis S, Anderson C, Moodie M, Levi C, Markus H, Coutts S.
2020-2021: Medical Research Futures Fund - BioMedTech Horizon Program (BMTH 3.0_0125), $346,500 Artificial Intelligence-based clinical decision support software for guiding acute stroke therapy
Yang Q, Gotla S, Parsons MW, Lin L. 2017-2023: NHMRC Project Grant (APP1132621), $979,270 Telehealth and Advanced CT Imaging Combined Study (TACTICS) Levi C, Bivard A, Attia J, Bladin C, Davis S, Donnan G, Anderson C, Campbell B, Parsons M, Grimley R 2015-2023: NHMRC Council Project Grant (APP1079696), $3,989,898 Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial Parsons M, Levi C, McElduff P, Lindley R, Desmond P, Albers G, Hacke W, Markus H, Campbell B, Phan T. -
- Oceanic Stroke
- Librexia
- Argenica
- Atridia
- Revive
- AustriCH
- Remedy II
- DAISE
- POST Eternal
- EMVISION
- TRIDENT
- STARS
- MIDAS II
- SICARIO: Stroke in patients with large Ischaemic Core: Assessment of Reperfusion therapy Impact on Outcome
- CASPER: Studies the use of daily low-dose colchicine to prevent recurrent stroke and heart attack
- MR-CASPER: Uses Magnetic Resonance Imaging to study the effects of colchicine on the brain and blood vessels of stroke survivors.
- CASPER-PET/CAP: Uses PET scanning to visualise blood vessel repair resulting from colchicine treatment in stroke survivors
-
- Profiling risk-factors and stroke outcomes in CALD communities
- Validation of new measure of pre-and post-stroke function, collected face-to-face, via telephone and AI.
-
A multifactorial risk prediction model for imaging characteristics of malignant infarction and unfavourable clinical outcomes in acute stroke survivors from First Nations communities.
Our group has been at the forefront of some of the most ground-breaking stroke trials of the last decade. In partnership with First Nations communities, we now seek to empower stroke survivors with a world-first model of care that integrates culturally specific risk factor assessments with advanced imaging, to enable personalised treatment decisions. This project has the potential to show substantial reductions in adverse stroke outcomes and, by recognising the unique characteristics of stroke in FN people, will be in the vanguard of a paradigm shift in stroke care.
Aims/Objectives
- To identify both modifiable and nonmodifiable risk factors that predict malignant (large core or fast core growth) hyperacute imaging profiles in First Nations peoples presenting with acute stroke.
- To identify both modifiable and nonmodifiable risk factors that predict poor functional outcomes in First Nations stroke survivors.
- To establish a multifactorial risk model to predict the likelihood of the emergence of malignant (large core or fast core growth) brain imaging features and unfavourable clinical outcomes in First Nations stroke patients, and to understand how the two interact.
- To translate this multifactorial risk model into a risk management and harm minimisation tool for clinical application in First Nations communities.
-
Deena Alysha Coilpillai Chelliah Vernon, ILP student 2023
Deena’s ILP project profiling risk factors and stroke outcomes in the Vietnamese community was completed as part of an ongoing research program in CALD communities with UNSW, Sydney Brain Centre, SWSLHD and strong community engagement. Rates of ICAD and ICH were significantly higher in Vietnamese patients compared to Caucasian patients. Only 11.8% (30) of Vietnamese patients received acute stroke intervention, compared to 29.3% (29) of Caucasian patients. Patients of Vietnamese background exhibited a higher in-hospital mortality rate and received acute stroke interventions less frequently. All-case in-hospital deaths were 87 (21.5%) in Vietnamese patients and 18 (12.5%) in Caucasians.
Pui Lok Annette Fung, UNSW Honours student 2023
Annette’s 2023 Honours project aimed to evaluate the feasibility of using AI to detect whether a person has experienced a stroke from different speech, language, eye gaze and facial symmetry patterns. This study demonstrated that AI models could differentiate LVO stroke participants from healthy controls through analysis of automated speech and voice features. This research was completed as part of an ongoing program of research validating a new measure of pre-and post-stroke function, the DBS24 (Driving Banking Shopping 24 hrs).
-
Year/Sponsor/Amount
Name
Chief Investigators
2019: Medical Research Futures Fund, $275,000 Melbourne Academic Centre for Health, Rapid Applied Research Translation grant (Tenecetaplase versus Alteplase Stroke Thrombolysis Evaluation on the Ambulance, TASTE-A) Bivard A, Parsons M, Churilov L, Campbell B, Yan B, Davis S, Donnan G Sanders L, Wijeratne T, Thijs V, Zhao H, Coote S. 2021-2022: UNSW Medicine & Health Cardiac, Vascular and Metabolic Medicine (CVMM) Theme: Big Ideas Seed Grant Scheme, AUD $150,000. Clinical and Imaging Characterisation of Stroke in First Nations, Pacific Islander, and other Culturally and Linguistically Diverse Australian Communities. Parsons M, Lin L, Blair C
2018: JT Reid Charitable Trust, $175,000 Migraine treatment: a personalised medicine approach using new MRI techniques. Parsons M, Yan B, Bivard A. 2018: Neuroscience Foundation Grant, $10,000 Post Stroke Cognitive Impairment
Alemseged F, Parsons M 2018: Neuroscience Foundation Grant, $10,000 Monitoring of Motor Function in Acute Stroke Yan B, Parsons M 2018 – 2022: Medical Research Future Fund Program Grant (APP1152282), $1,242,672 STOP-MSU: Stopping hemorrhage with Tranexamic acid commenced Prehospital in a Mobile Stroke Unit
Davis S, Parsons M, Campbell B, Yan B, Skafidas S, Desmond P
2017-2021: Canadian Institute of Health Research Program Grant (DC0190GP), $1,992,825 (CAD) TEMPO-2 – A randomized controlled trial of TNK-tPA versus standard of care for minor ischemic stroke with proven occlusion. Brown Coutts S, Goyal M, Hill, MD, Appireddy R, Barber P, Butcher K, Casaubon L, Demchuk A, Dowlatshahi D, Field T, Greisenegger S, Kelly P, Levi C, Mandzia J, Menon J, Muir K, Parsons M, Penn A, Robinson T, Sajobi T, Teitelbaum J, Yu A, Hunter G
2017-2021: NHMRC Program Grant (APP1113352), $13,787,375
Saving brain and changing practice in stroke
Davis S, Donnan G, Hankey G, Parsons M, Levi C, Campbell B 2016 – 2017: Canadian Institute of Health Research, Bridge Funding, $100,000 (CAD)
TEMPO-2 – A randomized controlled trial of TNK-tPA versus standard of care for minor ischemic stroke with proven occlusion. Coutts S, Hill M, Goyal M, Demchuk A, Greisenegger S, Kelly P, Menon B, Muir K, Parsons M. 2015-2019: NHMRC (APP1058650), $2,500,000 Centre for Research Excellence in Stroke Rehabilitation and Brain Recovery Investigators: Bernhardt J, Nilsson M, Carey L, van Vliet P, Cadilhac D, Parsons M, Bladin C, Middleton S, Levi C, Donnan G 2014-2017: Heart Foundation Future Leader Fellowship, $640,000 Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial Investigators: Parsons M. 2014: John Hunter Charitable Trust, $27,512
Implementation and assessment of cutting-edge contrast free perfusion imaging in ischemic stroke Principal Investigator: Parsons M. 2014: Hunter Medical Research Foundation, $50,000
Neuroimaging Biomarkers of Recovery: Longitudinal Imaging Study in the rehabilitation Phase post-Acute Ischemic Stroke (NEUROLISS) Investigators: Bivard A, Parsons M, Levi C 2014: Hunter Medical Research Foundation, $22,000 Individually tailoring stroke rehabilitation using advanced imaging Investigators: Bivard A, Parsons M 2014 Hunter Medical Research Foundation, $15,000 Director’s Award for Mid-Career Research 2014: Hunter Medical Research Foundation, $25,000 Mapping whole-brain metabolic networks Investigators: Thienel R, Karayanidis F, Todd J, Stanwell P, Parsons M, Levi C. 2012-2016: NHMRC Program Grant (APP1013612), $8,707,355 Improving Stroke Outcomes: Attenuating Progression and Recurrence Donnan G, Davis S, Hankey G, Howells D, Parsons M 2012-2014: Australian Research Council (ARC) Discovery Project Grant (DP120100340), $387,000 Cognitive flexibility from adolescence to senescence: variability associated with cognitive strategy and brain connectivity Karayanidis F, Forstmann B, Lenroot R, Parsons M, Michie P, Phillips N, Wagenmakers E-J
2012-2013: HMRI Donor Sponsored Project Grant - Dalara Foundation Stroke Research Project Grant, $20,000 Experimental brain imaging to investigate novel protective mechanisms of short duration body cooling after stroke Investigators: McLeod D, Spratt N, Parsons M, Levi, C. 2012: National Stroke Foundation, $17,367 Transcranial Direct Current Stimulation (tDCS): A new modality in stroke rehabilitation Investigators: Marquez J, Parsons M, Lagopoulos J, Karayanidis, Van Vliet P 2012: HMRI Project Grant, $16,000 Beyond Perfusion: MRS to characterise metabolic changes in the ischaemic brain